Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Melamed

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Urology Practice|April 28, 2026
Editorial CommentSam Melamed, Benjamin Waterman, Jonathan Bergman
Current Opinion in Urology|March 3, 2025
Generative artificial intelligence in oncologyConner Ganjavi, Sam Melamed, Brett Biedermann, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Urology Practice|April 28, 2026
Editorial CommentSam Melamed, Benjamin Waterman, Jonathan Bergman
Current Opinion in Urology|March 3, 2025
Generative artificial intelligence in oncologyConner Ganjavi, Sam Melamed, Brett Biedermann, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
Pageof 1